Clinical Trial

Development of Clinical and Biological Database

Study acronym: BCBInstitut
Recruiting
View on ClinicalTrials.gov →
Summary
The BCB is a tool: * for research in analytical and public health epidemiology, biological research and for the development of data useful for clinical research and therapeutic trials; * to help scientists understand and explain phenomena ranging from the interaction of molecules to the whole metabolism of the organism in normal and pathological situations; * to identify potential strategies for prevention, diagnosis, management and analysis of cancer subtypes. The creation of a broad clinical and biological prospective base dedicated to different types of cancer is essential for the development of such projects.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2018-02-27; most recent amendment 2025-02-11.
Trial Details
NCT Number NCT03449264
Lead Sponsor Institut du Cancer de Montpellier - Val d'Aurelle
Conditions Digestive Cancer, Gynecologic Cancer, Breast Cancer, Sarcoma
Enrollment 4,000 participants
Start Date 2017-07-27
Primary Completion 2027-11 (estimated)
Study Completion 2037-11 (estimated)
Updated on ClinicalTrials.gov 2025-02-12